Gene Symbol | Pearson Correlation Coefficient |
---|---|
PPP1R11 | 0.944 |
MTX2 | 0.943 |
RRAGA | 0.941 |
ABCF3 | 0.94 |
GOT2 | 0.94 |
SEC61A2 | 0.94 |
MICU1 | 0.938 |
PPME1 | 0.938 |
IDH3B | 0.936 |
RNF34 | 0.936 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.653 |
OR4F29 | -0.616 |
MTRNR2L6 | -0.411 |
MTRNR2L9 | -0.403 |
MTRNR2L10 | -0.399 |
IL18RAP | -0.364 |
S100A12 | -0.363 |
KCNJ15 | -0.36 |
FCGR3B | -0.357 |
CST7 | -0.352 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of ANAPC7 mRNA" | 21346803 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of ANAPC7 mRNA" | 21346803 |
D000082 | Acetaminophen | Acetaminophen affects the expression of ANAPC7 mRNA | 17562736 |
D001151 | Arsenic | Arsenic affects the methylation of ANAPC7 gene | 25304211 |
D001280 | Atrazine | Atrazine results in increased expression of ANAPC7 mRNA | 22378314 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ANAPC7 mRNA | 22228805 |
C006780 | bisphenol A | bisphenol A results in increased expression of ANAPC7 mRNA | 25181051 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of ANAPC7 mRNA | 23741332 |
D019327 | Copper Sulfate | Copper Sulfate affects the expression of ANAPC7 mRNA | 19549813 |
D003375 | Coumestrol | Coumestrol results in increased expression of ANAPC7 mRNA | 19167446 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of ANAPC7 mRNA] | 27941970 |
D004026 | Dieldrin | Dieldrin results in decreased expression of ANAPC7 mRNA | 23041725 |
D004791 | Enzyme Inhibitors | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ANAPC7 protein | 23301498 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANAPC7 mRNA | 22079256 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of ANAPC7 mRNA | 17555576 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of ANAPC7 mRNA | 17942748 |
D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in decreased expression of ANAPC7 mRNA | 23649840 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased methylation of ANAPC7 gene | 21212295 |
C044361 | M-VAC protocol | ANAPC7 protein results in decreased susceptibility to M-VAC protocol | 15814643 |
C022838 | nickel chloride | nickel chloride affects the expression of ANAPC7 mRNA | 22546817 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of ANAPC7 mRNA | 18301758 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANAPC7 mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of ANAPC7 mRNA | 22079256 |
D013629 | Tamoxifen | Tamoxifen affects the expression of ANAPC7 mRNA | 17555576 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of ANAPC7 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased methylation of ANAPC7 gene | 21212295 |
D014520 | Urethane | Urethane results in decreased expression of ANAPC7 mRNA | 28818685 |
D014635 | Valproic Acid | Valproic Acid affects the expression of ANAPC7 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of ANAPC7 mRNA | 23179753|2519280 |
C025643 | vinclozolin | vinclozolin results in decreased expression of ANAPC7 mRNA | 23034163 |
C111237 | vorinostat | vorinostat results in increased expression of ANAPC7 mRNA | 27188386 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005515 | protein binding | - | IPI | 20360068 26496610 27173435 |
GO:0019903 | protein phosphatase binding | - | IPI | 21241890 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0007049 | cell cycle | - | IEA | - |
GO:0031145 | anaphase-promoting complex-dependent catabolic process | - | TAS | - |
GO:0051301 | cell division | - | IEA | - |
GO:0070979 | protein K11-linked ubiquitination | - | IDA | 18485873 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005634 | nucleus | - | IDA | 21241890 |
GO:0005654 | nucleoplasm | - | TAS | - |
GO:0005680 | anaphase-promoting complex | - | IDA | 16364912 21926987 |
GO:0005829 | cytosol | - | TAS | - |
KEGG ID | KEGG Term |
---|---|
hsa04110 | Cell cycle |
hsa04114 | Oocyte meiosis |
hsa04120 | Ubiquitin mediated proteolysis |
hsa04914 | Progesterone-mediated oocyte maturation |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1280218 | Adaptive Immune System | TAS |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | TAS |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | TAS |
R-HSA-1640170 | Cell Cycle | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | TAS |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | TAS |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | TAS |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | TAS |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | TAS |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | TAS |
R-HSA-176407 | Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | TAS |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | TAS |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
R-HSA-176412 | Phosphorylation of the APC/C | TAS |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | TAS |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | TAS |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | TAS |
R-HSA-2262752 | Cellular responses to stress | TAS |
R-HSA-2467813 | Separation of Sister Chromatids | TAS |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | TAS |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | TAS |
R-HSA-2559583 | Cellular Senescence | TAS |
R-HSA-453276 | Regulation of mitotic cell cycle | TAS |
R-HSA-68882 | Mitotic Anaphase | TAS |
R-HSA-68886 | M Phase | TAS |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | TAS |
R-HSA-69052 | Switching of origins to a post-replicative state | TAS |
R-HSA-69239 | Synthesis of DNA | TAS |
R-HSA-69242 | S Phase | TAS |
R-HSA-69278 | Cell Cycle, Mitotic | TAS |
R-HSA-69306 | DNA Replication | TAS |
R-HSA-69618 | Mitotic Spindle Checkpoint | TAS |
R-HSA-69620 | Cell Cycle Checkpoints | TAS |
R-HSA-8953897 | Cellular responses to external stimuli | TAS |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | TAS |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
29328493 | Meta-analysis of mRNA expression profiles to identify differentially expressed genes in lung adenocarcinoma tissue from smokers and non-smokers. (2018 Mar) | He X | Oncol Rep |